Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0044
Host Cell : CHO-K1 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0044 |
| Description | This cell line is a stably transfected cell line which expresses Human CD40 without any tag. |
| Target Gene | CD40 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | CHO-K1 |
| Host Cell Species | Cricetulus griseus (Chinese hamster) |
| Source | CHO-K1 |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | CD40 CD40 molecule [ Homo sapiens (human) ] |
| Gene Symbol | CD40 |
| Synonyms | p50; Bp50; CDW40; TNFRSF5 |
| GeneID | 958 |
| Uni ProtID | P25942 |
| Chromosome Location | 20q13.12 |
This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3).
A: The Human CD40 Stable Cell Line-CHO offers several advantages for antibody production. Firstly, it is a mammalian cell line, which is known for its ability to perform complex post-translational modifications, leading to antibodies with high similarity to those produced in humans. Secondly, the stable expression of CD40 in CHO cells can facilitate the study of CD40 signaling pathways and its role in immune responses. Lastly, CHO cells are well-characterized and have a robust history in biotechnology, making them a reliable choice for large-scale production.
A: The Human CD40 Stable Cell Line-CHO provides a platform to study the activation and regulation of immune cells. CD40 is a critical co-stimulatory molecule involved in the activation of B cells and other immune cells. By using this cell line, researchers can investigate the downstream signaling pathways activated by CD40 ligation, which can lead to a better understanding of immune cell activation and the development of therapeutic strategies.
A: Maintaining and expanding the Human CD40 Stable Cell Line-CHO can be challenging due to the need for specific culture conditions to ensure stable expression of CD40. These cells may require selective pressure, such as antibiotic resistance markers, to maintain the CD40 expression. Additionally, the cells need to be regularly monitored for genetic stability and potential mutations that could affect CD40 expression or cell function.
A: The Human CD40 Stable Cell Line-CHO enables researchers to investigate the interactions between CD40 and CD40 ligand (CD40L), which is a critical aspect of immune cell communication. By expressing CD40 on the cell surface, this cell line allows for the study of CD40L binding, signaling, and the subsequent cellular responses, providing insights into the mechanisms of immune cell activation and regulation.
A: The Human CD40 Stable Cell Line-CHO can be utilized in vaccine development by producing antibodies that target CD40, which can enhance the immune response to a vaccine. Additionally, the cell line can be used to study the effects of CD40 activation on antigen-presenting cells, which can inform strategies for improving vaccine efficacy.
A: The Human CD40 Stable Cell Line-CHO provides a model system to study the role of CD40 signaling in B cell development and maturation. By manipulating the expression of CD40 and its ligands, researchers can investigate the impact of CD40 signaling on B cell proliferation, differentiation, and antibody production, which is crucial for understanding the adaptive immune response.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
This CD40 stable cell line has been an exceptional asset for our ligand binding and activation assays. It behaves exactly as described in the specification sheet, with stable expression that doesn't drop off over time. I highly recommend Creative Biogene for anyone needing reliable immune receptor lines.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.